Multiple Myeloma DREAM Challenge
Accelerating the development and evaluation of models for risk stratification of patients to improve therapeutic decision-making
Multiple myeloma (MM) is a cancer of the plasma cells in the bone marrow, and its clinical course depends on a complex interplay of clinical traits and molecular characteristics of the plasma cells. Since risk-adapted therapy is becoming standard of care, there is an urgent need for a precise risk stratification model to assist in therapeutic decision-making. While progress has been made, there remains a significant opportunity to improve patient stratification to optimize treatment and to develop new therapies for high-risk patients. The MM DREAM Challenge aims to accelerate the development and evaluation of such risk models in multiple myeloma.
More Challenges and Benchmarking Projects
DREAM Challenges powered by Sage Bionetworks
Community competitions on fundamental questions about systems biology and translational medicine, and advance computational methods
Learn MoreWellcome Trust partners with Sage Bionetworks
The Wellcome Data Re-use Prizes show how data re-use can generate new insights that may lead to vital health benefits
Learn MoreUp 4 A Challenge
Using innovative approaches to identify novel pathways involved in breast cancer susceptibility in order to generate new biological hypotheses
Learn More